These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11247532)

  • 21. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An automated system for determining drug solubility based on laser monitoring technique.
    Jouyban-Gharamaleki V; Jouyban-Gharamaleki K; Shayanfar A; Khoubnasabjafari M; Jouyban A
    J Lab Autom; 2015 Feb; 20(1):3-9. PubMed ID: 25331492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations.
    Bhardwaj S; Lipert M; Bak A
    J Pharm Sci; 2017 Jan; 106(1):31-38. PubMed ID: 27665129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New uses for old drugs.
    Chong CR; Sullivan DJ
    Nature; 2007 Aug; 448(7154):645-6. PubMed ID: 17687303
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
    DeWitte RS; Robins RH
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence-based liver microsomal assay for screening of pharmaceutical reactive metabolites using a glutathione conjugated 96-well plate.
    Ma X; Chan EC
    Bioconjug Chem; 2010 Jan; 21(1):46-55. PubMed ID: 19957910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The silent treatment.
    Smith C
    Nature; 2003 Mar; 422(6929):342. PubMed ID: 12646928
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review.
    Pestieau A; Evrard B
    Eur J Pharm Sci; 2017 May; 102():203-219. PubMed ID: 28315463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High content drug screening and its application].
    Zhang L; Du GH
    Yao Xue Xue Bao; 2005 Jun; 40(6):486-90. PubMed ID: 16144310
    [No Abstract]   [Full Text] [Related]  

  • 31. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates.
    Bevan CD; Lloyd RS
    Anal Chem; 2000 Apr; 72(8):1781-7. PubMed ID: 10784141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.
    Kryscio DR; Sathe PM; Lionberger R; Yu L; Bell MA; Jay M; Hilt JZ
    AAPS PharmSciTech; 2008; 9(1):84-6. PubMed ID: 18446465
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of aqueous solubility by heating and equilibration: a technical note.
    Loftsson T; Hreinsdóttir D
    AAPS PharmSciTech; 2006 Jan; 7(1):E4. PubMed ID: 16584163
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of acidity constants of sparingly soluble drugs in aqueous solution by the internal standard capillary electrophoresis method.
    Cabot JM; Fuguet E; Rosés M
    Electrophoresis; 2014 Dec; 35(24):3564-9. PubMed ID: 25229479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
    Laitinen R; Lahtinen J; Silfsten P; Vartiainen E; Jarho P; Ketolainen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):181-9. PubMed ID: 20116958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME).
    Dai WG; Dong LC; Shi X; Nguyen J; Evans J; Xu Y; Creasey AA
    J Pharm Sci; 2007 Nov; 96(11):2957-69. PubMed ID: 17705287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.
    Fura A; Shu YZ; Zhu M; Hanson RL; Roongta V; Humphreys WG
    J Med Chem; 2004 Aug; 47(18):4339-51. PubMed ID: 15317447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.